Ampliz vs Lead411: Honest Comparison (2026)

Ampliz vs Lead411: Honest Comparison (2026)

You're comparing Ampliz and Lead411 because someone on your team suggested one of these tools, and now you need to figure out if it's worth a demo. Here's the thing: they serve fundamentally different buyers. Pick the wrong one and you'll waste a month of trials and a quarter of pipeline momentum.

30-Second Verdict

Pick Ampliz if you're prospecting into healthcare or APAC markets. It's purpose-built for those niches and thin everywhere else.

Pick Lead411 if you're an SMB sales team in North America that wants intent triggers, growth signals, and direct dials.

Skip both if you need verified emails at scale without export caps or niche-market limitations - we'll get to that.

Feature Comparison at a Glance

The review volume gap tells its own story - Lead411 has roughly 68x more G2 reviews, which means far more real-world validation. We couldn't find meaningful Reddit discussion for either product, so G2 and Capterra are where the honest feedback lives.

Ampliz: Healthcare Data, Not Much Else

Let's be direct. Ampliz is a healthcare prospecting tool that happens to have a general B2B database bolted on. If you're targeting physicians, hospitals, clinics, or labs - or expanding into APAC markets where other databases have blind spots - the healthcare intelligence is genuinely specialized. We're talking HCP directories, NPI lookup, and physician-level filtering that competitors simply don't offer. G2 reviewers praise the DACH region data quality specifically, noting fewer bounces and valid direct dials.

Outside healthcare or APAC? Don't bother. One G2 reviewer put it bluntly: it "doesn't work for any other market except healthcare." The UI feels dated, exporting takes more clicks than it should, and with only 7 G2 reviews total, you're betting on a tool without much community validation behind it.

Pricing is straightforward: free tier with 10 credits, $50/mo for 100 credits, or $600/yr discounted to $480/yr with 100 credits per month. Healthcare plans are custom-priced, likely $200-$500/mo based on comparable niche data providers.

Lead411: The Pricing Doesn't Match the Marketing

Lead411's homepage says "starting at $49/month." Real-world pricing tells a different story. A third-party pricing teardown lists Spark at $99/month on monthly billing, while G2's pricing snippet shows Spark Annual at $490/year per seat on a one-year contract.

Above Spark, the tiering gets expensive fast. Ignite adds direct dials, more flexible export limits, enhanced integrations, and an AI search assistant - commonly positioned in the $3K-$8K/year range. Blaze adds unlimited exports, optional API access, optional intent data, and higher-touch onboarding, running $6K+/year. Bombora intent is an add-on at $1,000/seat/year. Budget accordingly.

What you get for that money is solid. The database covers 450M B2B contacts with triple-verified emails using SMTP, human verification, and email-open validation, plus double-verified direct dials. Lead411 re-verifies emails every 3 months, tracks 30K technologies, and integrates with 27 CRMs (see our breakdown of CRM automation tools if you're evaluating workflow fit). The 4.5/5 G2 rating across 477 reviews and 4.7/5 on Capterra across 76 reviews reflect genuine satisfaction, particularly around ease of use. The Bombora integration and growth triggers - funding rounds, leadership changes, new office openings - give reps conversation starters that generic databases don't. One Capterra reviewer reported a 60% reduction in cost-per-qualified-lead after switching.

The catch? Export limits on lower tiers. Spark caps you at roughly 200 exports/month, with $0.50 per extra export. We've seen teams burn through that in under a week. And the top G2 complaint - outdated contacts, flagged 13 times - shows up repeatedly, especially for niche markets and smaller companies.

When to Pick Each Tool

Pick Ampliz if:

• You're targeting healthcare professionals specifically
• You're expanding into APAC or DACH markets
• Your budget is under $50/mo and you only need niche contacts

Pick Lead411 if:

• You're an SMB sales team focused on North America
• Intent triggers and growth signals matter to your outreach cadence (pair this with a tighter outbound prospecting stack)
• You're willing to manage export limits or pay for Blaze-tier access

Pick neither if:

• You need verified emails at scale without credit confusion (here’s how to verify email addresses in bulk without wrecking deliverability)
• You're an agency running multi-client campaigns where domain reputation is everything
• You want self-serve access without annual contracts or opaque tier pricing

Look, most teams weighing Ampliz vs Lead411 actually need neither. If your average deal size is under $15k and you're running volume outbound, a specialized healthcare database and a capped SMB tool are both the wrong shape. You need accurate emails, fresh data, and no artificial limits on how fast you can move (especially if you’re tracking pipeline bottlenecks and trying to remove friction).

The Email-First Alternative

FAQ

Is Ampliz good for non-healthcare prospecting?

No. G2 reviews consistently confirm Ampliz shines in healthcare, and one reviewer states it "doesn't work for any other market except healthcare." General B2B data has notable gaps in contact completeness and job title accuracy outside that vertical.

Does Lead411 really start at $49/month?

That's the homepage "starting at" price, but real-world costs vary. G2's pricing snippet shows Spark Annual at $490/year per seat, and third-party breakdowns list Spark at $99/month on monthly billing. Expect $3K-$8K/year once you need direct dials or higher export limits on Ignite.

Can I use Lead411 for international prospecting?

Lead411's strength is North American data. International coverage exists but it's thinner, and G2 reviewers flag outdated contacts more often outside the US. For APAC, Ampliz is stronger. For global coverage with consistent freshness, Prospeo's 300M+ profile database refreshes weekly across all regions.